• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症生存观察性研究中的现患病例:它们会使风险比估计产生偏差吗?

Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?

作者信息

Azzato E M, Greenberg D, Shah M, Blows F, Driver K E, Caporaso N E, Pharoah P D P

机构信息

Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK.

出版信息

Br J Cancer. 2009 Jun 2;100(11):1806-11. doi: 10.1038/sj.bjc.6605062. Epub 2009 Apr 28.

DOI:10.1038/sj.bjc.6605062
PMID:19401693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2695697/
Abstract

Observational epidemiological studies often include prevalent cases recruited at various times past diagnosis. This left truncation can be dealt with in non-parametric (Kaplan-Meier) and semi-parametric (Cox) time-to-event analyses, theoretically generating an unbiased hazard ratio (HR) when the proportional hazards (PH) assumption holds. However, concern remains that inclusion of prevalent cases in survival analysis results inevitably in HR bias. We used data on three well-established breast cancer prognosticators - clinical stage, histopathological grade and oestrogen receptor (ER) status - from the SEARCH study, a population-based study including 4470 invasive breast cancer cases (incident and prevalent), to evaluate empirically the effectiveness of allowing for left truncation in limiting HR bias. We found that HRs of prognostic factors changed over time and used extended Cox models incorporating time-dependent covariates. When comparing Cox models restricted to subjects ascertained within six months of diagnosis (incident cases) to models based on the full data set allowing for left truncation, we found no difference in parameter estimates (P=0.90, 0.32 and 0.95, for stage, grade and ER status respectively). Our results show that use of prevalent cases in an observational epidemiological study of breast cancer does not bias the HR in a left truncation Cox survival analysis, provided the PH assumption holds true.

摘要

观察性流行病学研究通常纳入在过去不同时间确诊的现患病例。这种左截断问题可在非参数(Kaplan-Meier)和半参数(Cox)生存分析中处理,理论上在比例风险(PH)假设成立时可产生无偏风险比(HR)。然而,仍有人担心在生存分析中纳入现患病例不可避免地会导致HR偏差。我们使用了基于人群的SEARCH研究中的数据,该研究纳入了4470例浸润性乳腺癌病例(新发病例和现患病例),涉及三个已确立的乳腺癌预后因素——临床分期、组织病理学分级和雌激素受体(ER)状态,以实证评估考虑左截断在限制HR偏差方面的有效性。我们发现预后因素的HR随时间变化,并使用了纳入时间依存协变量的扩展Cox模型。当将限于诊断后六个月内确诊的受试者(新发病例)的Cox模型与基于允许左截断的完整数据集的模型进行比较时,我们发现参数估计值没有差异(分期、分级和ER状态的P值分别为0.90、0.32和0.95)。我们的结果表明,在乳腺癌观察性流行病学研究中使用现患病例,在左截断Cox生存分析中不会使HR产生偏差,前提是PH假设成立。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c0/2695697/3ed53c410cd6/6605062f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c0/2695697/cc46a049fcf9/6605062f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c0/2695697/3ed53c410cd6/6605062f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c0/2695697/cc46a049fcf9/6605062f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59c0/2695697/3ed53c410cd6/6605062f2.jpg

相似文献

1
Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?癌症生存观察性研究中的现患病例:它们会使风险比估计产生偏差吗?
Br J Cancer. 2009 Jun 2;100(11):1806-11. doi: 10.1038/sj.bjc.6605062. Epub 2009 Apr 28.
2
Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.初诊时患有乳腺癌骨转移的女性,根据肿瘤亚型的预后因素和生存情况:一项基于 SEER 的研究。
BMC Cancer. 2020 Nov 13;20(1):1102. doi: 10.1186/s12885-020-07593-8.
3
Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.乳腺癌脑转移患者无脑转移间隔的预后价值。
World Neurosurg. 2019 Aug;128:e157-e164. doi: 10.1016/j.wneu.2019.04.072. Epub 2019 Apr 26.
4
Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.早期和局部晚期化生性乳腺癌:监测、流行病学和最终结果(SEER)2010-2014 年按受体状态的表现和生存。
Oncologist. 2018 Apr;23(4):481-488. doi: 10.1634/theoncologist.2017-0398. Epub 2018 Jan 12.
5
Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.FOXP3+肿瘤浸润淋巴细胞在乳腺癌中的预后意义取决于雌激素受体和人表皮生长因子受体2的表达状态以及同时存在的细胞毒性T细胞浸润情况。
Breast Cancer Res. 2014 Sep 6;16(5):432. doi: 10.1186/s13058-014-0432-8.
6
Nodal ratio of positive to excised nodes, but not number of positive lymph nodes is better to predict group to avoid chemotherapy among postmenopausal ER-positive, lymph node-positive T1-T2 breast cancer patients.在绝经后雌激素受体阳性、淋巴结阳性的T1-T2期乳腺癌患者中,阳性淋巴结与切除淋巴结的比值比阳性淋巴结数量更能准确预测分组以避免化疗。
J Cancer Res Ther. 2015 Oct-Dec;11(4):740-5. doi: 10.4103/0973-1482.154937.
7
Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico.波多黎各某医院样本中的乳腺癌分子亚型与生存情况。
Cancer Med. 2013 Jun;2(3):343-50. doi: 10.1002/cam4.78. Epub 2013 Apr 18.
8
Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.对侧预防性乳房切除术对雌激素受体阴性的年轻乳腺癌女性患者并无生存获益。
Ann Surg Oncol. 2014 Oct;21(10):3231-9. doi: 10.1245/s10434-014-3956-3. Epub 2014 Aug 1.
9
Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.白人女性乳腺癌生存中乳腺癌亚型、Ki-67 增殖指数、年龄和病理肿瘤特征的预后价值。
Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059. Epub 2012 Dec 13.
10
Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience.乳腺癌患者无转移间期:三十年趋势和预后因素的时间依赖性。基于单机构经验的回顾性分析。
Breast. 2018 Feb;37:80-88. doi: 10.1016/j.breast.2017.10.008. Epub 2017 Nov 2.

引用本文的文献

1
Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a Mutation.铁蛋白重链的表达与定位可预测携带特定突变的乳腺癌患者的复发情况
Cancers (Basel). 2023 Dec 20;16(1):28. doi: 10.3390/cancers16010028.
2
Differential discontinuation by covert use status in Kenya.肯尼亚按秘密使用状况进行的差异停药情况。
Contracept X. 2023 Oct 16;5:100102. doi: 10.1016/j.conx.2023.100102. eCollection 2023.
3
Determinants of survival in patients with chronic heart failure: a population-based study in Reggio Emilia, Italy.

本文引用的文献

1
Risk factors for the incidence of breast cancer: do they affect survival from the disease?乳腺癌发病的风险因素:它们会影响该疾病的生存率吗?
J Clin Oncol. 2008 Jul 10;26(20):3310-6. doi: 10.1200/JCO.2006.10.3168.
2
Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.细胞周期调控基因常见种系遗传变异对乳腺癌生存的影响:基于人群队列的研究结果
Breast Cancer Res. 2008;10(3):R47. doi: 10.1186/bcr2100. Epub 2008 May 28.
3
Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
意大利雷焦艾米利亚基于人群的慢性心力衰竭患者生存的决定因素研究。
ESC Heart Fail. 2023 Dec;10(6):3646-3655. doi: 10.1002/ehf2.14557. Epub 2023 Oct 5.
4
FMRP expression in primary breast tumor cells correlates with recurrence and specific site of metastasis.原发性乳腺癌细胞中 FMRP 的表达与复发和特定转移部位相关。
PLoS One. 2023 Jun 28;18(6):e0287062. doi: 10.1371/journal.pone.0287062. eCollection 2023.
5
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.乳腺癌患者携带胚系 BRCA1/2 致病性变异体接受放疗后的对侧乳腺癌风险。
J Natl Cancer Inst. 2023 Nov 8;115(11):1318-1328. doi: 10.1093/jnci/djad116.
6
Incorporating progesterone receptor expression into the PREDICT breast prognostic model.将孕激素受体表达纳入 PREDICT 乳腺癌预后模型。
Eur J Cancer. 2022 Sep;173:178-193. doi: 10.1016/j.ejca.2022.06.011. Epub 2022 Aug 4.
7
Increased risk of being diagnosed with endometriosis in patients with Systemic lupus erythematosus: a population-based cohort study in Taiwan.在系统性红斑狼疮患者中,子宫内膜异位症的诊断风险增加:一项基于人群的台湾队列研究。
Sci Rep. 2022 Aug 3;12(1):13336. doi: 10.1038/s41598-022-17343-4.
8
Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium.非裔美国妇女中卵巢上皮癌生存的种族差异:非洲裔美国妇女卵巢癌联盟中相关因素的研究。
Int J Cancer. 2022 Oct 15;151(8):1228-1239. doi: 10.1002/ijc.34141. Epub 2022 Jun 30.
9
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.BRCA1/BRCA2 相关的 pT1 乳腺癌患者的生存情况,一项队列研究。
Breast Cancer Res Treat. 2022 Jul;194(1):159-170. doi: 10.1007/s10549-022-06608-1. Epub 2022 May 4.
10
Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients.常见维持性药物对老年 COVID-19 患者风险和严重程度的影响。
PLoS One. 2022 Apr 18;17(4):e0266922. doi: 10.1371/journal.pone.0266922. eCollection 2022.
细胞周期基因常见种系遗传变异对卵巢癌生存率的影响。
Clin Cancer Res. 2008 Feb 15;14(4):1090-5. doi: 10.1158/1078-0432.CCR-07-1195.
4
Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.抗氧化防御基因的常见种系遗传变异与乳腺癌诊断后的生存情况
J Clin Oncol. 2007 Jul 20;25(21):3015-23. doi: 10.1200/JCO.2006.10.0099.
5
Effect of germ-line genetic variation on breast cancer survival in a population-based study.一项基于人群的研究中种系基因变异对乳腺癌生存的影响。
Cancer Res. 2002 Jun 1;62(11):3052-7.
6
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.通过免疫组织化学检测雌激素受体状态在预测乳腺癌辅助内分泌治疗反应方面优于配体结合测定法。
J Clin Oncol. 1999 May;17(5):1474-81. doi: 10.1200/JCO.1999.17.5.1474.
7
Survival analysis in natural history studies of disease.疾病自然史研究中的生存分析。
Stat Med. 1989 Oct;8(10):1255-68. doi: 10.1002/sim.4780081009.